Selected Publications
ZMB Publications
Selected Publications
The list provides selected publications of the ZMB from 2004 to 2021, published in the journals listed below.
You can narrow the list down by year and author. If an error accured or no data was found, please reload or reset the page.
(View all ZMB publications via the interface of the university bibliography).
Journals
- ACS Nano
- Acta Neuropathologica
- Advanced Drug Delivery Reviews
- All Nature Journals
- American Journal of Human Genetics
- Angewandte Chemie International Edition
- Annals of Oncology
- Annual Review of Biochemistry
- Annual Review of Genetics
- Annual Review of Microbiology
- Biomaterials
- Biotechnology Advances
- Blood
- Brain
- Cancer Cell
- Cancer Discovery
- Cancer Research
- Cell
- Clinical Cancer Research
- Cell Reports
- Chemical Reviews
- Chemical Society Reviews
- Circulation
- Circulation Research
- Current Biology
- eLife
- EMBO Molecular Medicine
- EMBO Reports
- Endocrine Reviews
- European Heart Journal
- FEMS Microbiology Reviews
- Gastroenterology
- Genes and Development
- Gut
- Hepatology
- Immunity
- Immunological Reviews
- JAMA: Journal of the American Medical Association
- JAMA Oncology
- JAMA Neurology
- Journal of Hepatology
- Journal of the American Chemical Society
- Journal of the American Medical Association
- Journal of Clinical Oncology
- Journal of Hepatology
- Lancet
- Leukemia
- Molecular Cell
- Molecular Psychiatry
- Natural Product Research
- Nature
- Nature Biotechnology
- Nature Cancer
- Nature Cell Biology
- Nature Chemical Biology
- Nature Communications
- Nature Genetics
- Nature Medicine
- Nature Methods
- Nature Nanotechnology
- Nature Reviews Clinical Oncology
- Nature Reviews Molecular Cell Biology
- Nature Reviews Neurology
- Nature Structural & Molecular Biology
- Neuro-Oncology
- Nucleic Acids Research
- Proceedings of the National Academy of Sciences of the United States of America Science
- Science
- Science Advances
- Small
- The British Journal of Cancer
- The EMBO Journal
- The Journal of Cell Biology
- The Journal of Clinical Investigation (JCI)
- The Lancet
- The Lancet Diabetes and Endocrinology
- The Lancet Gastroenterology & Hepatology
- The Lancet Infectious Diseases
- The Lancet Neurology
- The Lancet Oncology
- The New England Journal of Medicine
- Trends in Neurosciences
- Trends in Pharmacological Sciences
There were 1167 publications found
-
Condensins regulate resection-dependent DNA double-strand break repair pathways in replicated chromatinIn: Nucleic Acids Research, Vol. 54, 2026, Nr. 4, gkag076DOI (Open Access)
-
Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinomaIn: Nature Communications, Vol. 17, 2026, Nr. 1, 1476DOI (Open Access)
-
The accessory adapters FAF1, FAF2, and UBXN7 accelerate proteasomal degradation by increasing prior p97-mediated substrate unfoldingIn: Science Advances, Vol. 12, 2026, Nr. 10, eaea7381DOI (Open Access)
-
CUL4A-DDB1-DCAF10 is an N-recognin for N-terminally acetylated Src kinasesIn: Nature Communications, Vol. 17, 2026, Nr. 1, 132DOI (Open Access)
-
M18BP1 valency and a distributed interaction footprint determine epigenetic centromere specification in humansIn: The EMBO Journal, 2026, in pressDOI (Open Access)
-
Molecular requirements for PLK1 activation by T-loop phosphorylationIn: The EMBO Journal, Vol. 45, 2026, Nr. 5, pp. 1496 – 1536DOI (Open Access)
-
Activated ATF6α is a hepatic tumour driver restricting immunosurveillanceIn: Nature, 2026, in pressDOI (Open Access)
-
Covalent modification of a glutamic acid inspired by HaloTag technologyIn: Nature Communications, Vol. 17, 2026, Nr. 1, 1257DOI (Open Access)
-
Vibostolimab coformulated with pembrolizumab versus pembrolizumab alone as adjuvant therapy for high-risk stage IIB–IV melanoma (KEYVIBE-010) : A randomised, double-blind, phase 3 studyIn: The Lancet Oncology, Vol. 27, 2026, Nr. 3, pp. 327 – 339DOI (Open Access)
-
Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial)In: European Heart Journal, Vol. 47, 2026, Nr. 9, pp. 1034 – 1046DOI (Open Access)
-
Deep Learning-Derived Sarcopenia Marker Predicts Benefit from Anti-EGFR Therapy in Patients with RAS Wild-type Metastatic Colorectal CancerIn: Clinical Cancer Research, Vol. 32, 2026, Nr. 5, pp. 938 – 946DOI (Open Access)
-
Sulfated glycosaminoglycans inhibit LCMV entry and modulate antiviral immunity and pathologyIn: EMBO Molecular Medicine, 2026, in pressDOI (Open Access)
-
Type I IFN-dependent FcγRIV signaling in murine monocytes promotes lethal anaphylaxis during viral infectionsIn: The Journal of Clinical Investigation (JCI), Vol. 136, 2026, Nr. 4DOI (Open Access)
-
CCL3 is produced by aged neutrophils across cancers and promotes tumor growthIn: Cancer Cell, Vol. 44, 2026, Nr. 3, pp. 624 – 640.e12DOI (Open Access)
-
Ancient co-option of LTR retrotransposons as yeast centromeresIn: Nature, 2026, in pressDOI (Open Access)
-
Interplay of SLC33A1-dependent and -independent Golgi sialic acid O-acetylation in CASD1 catalysisIn: Nature Communications, Vol. 17, 2026, Nr. 1, 3156DOI (Open Access)
-
Genetic and functional analyses of CTBP2 in anorexia nervosa and body weight regulationIn: Molecular Psychiatry, Vol. 30, 2025, Nr. 5, pp. 1836 – 1846DOI (Open Access)
-
HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replicationIn: Journal of Hepatology, Vol. 82, 2025, Nr. 5, pp. 805 – 815DOI (Open Access)
-
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialIn: Nature Medicine, Vol. 31, 2025, Nr. 1, pp. 152 – 164DOI (Open Access)
-
Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancerIn: Nature Communications, Vol. 16, 2025, Nr. 1, 335DOI (Open Access)
-
High Glucose Contribution to the TCA Cycle Is a Feature of Aggressive Non-Small Cell Lung Cancer in PatientsIn: Cancer Discovery, Vol. 15, 2025, Nr. 4, pp. 702 – 716DOI (Open Access)
-
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced MelanomaIn: The New England Journal of Medicine, Vol. 392, 2025, Nr. 1, pp. 11 – 22DOI, Online Full Text (Open Access)
-
Nitro-oleic acid enhances mitochondrial metabolism and ameliorates heart failure with preserved ejection fraction in miceIn: Nature Communications, Vol. 16, 2025, Nr. 1, 3933DOI (Open Access)
-
Discordance, accuracy and reproducibility study of pathologists’ diagnosis of melanoma and melanocytic tumorsIn: Nature Communications, Vol. 16, 2025, Nr. 1, 789DOI (Open Access)
-
Immunothrombolytic monocyte-neutrophil axes dominate the single-cell landscape of human thrombosis and correlate with thrombus resolutionIn: Immunity, Vol. 58, 2025, Nr. 5, pp. 1343 – 1358.e13DOI (Open Access)
-
PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinomaIn: Cell Reports, Vol. 44, 2025, Nr. 4, 115541DOI (Open Access)
-
Molecular determinants of sotorasib clinical efficacy in KRASG12C-mutated non-small-cell lung cancerIn: Nature Medicine, Vol. 31, 2025, Nr. 8, pp. 2755 – 2767DOI (Open Access)
-
Oxygen evolution reaction on IrO₂(110) is governed by Walden-type mechanismsIn: Nature Communications, Vol. 16, 2025, Nr. 1, 6137DOI (Open Access)
-
The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITAIn: eLife, Vol. 14, 2025, e96414DOI, Online Full Text (Open Access)
-
Gemtuzumab ozogamicin in first-line treatment of CBF-AML : Insights from a retrospective multi-center analysisIn: Leukemia, Vol. 39, 2025, Nr. 9, pp. 2174 – 2180DOI (Open Access)
-
Muscle growth by sarcomere divisionsIn: Science Advances, Vol. 11, 2025, Nr. 28, eadw9445DOI (Open Access)
-
Renaissance of Chlorine Evolution Reaction : Emerging Theory and Catalytic MaterialsIn: Angewandte Chemie International Edition, Vol. 64, 2025, Nr. 1, e202417293DOI (Open Access)
-
Multistate kinetics of the syringe-like injection mechanism of Tc toxinsIn: Science Advances, Vol. 11, 2025, Nr. 1, eadr2019DOI (Open Access)
-
[⁶⁸Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation : A single-centre, single-arm, interventional, phase 2 trialIn: The Lancet Oncology, Vol. 26, 2025, Nr. 9, pp. 1204 – 1214DOI (Open Access)
-
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanomaIn: Annals of Oncology, Vol. 36, 2025, Nr. 10, pp. 1166 – 1177DOI (Open Access)
-
Final overall survival and safety analyses of the phase III PSMAfore trial of [¹⁷⁷Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancerIn: Annals of Oncology, Vol. 36, 2025, Nr. 11, pp. 1319 – 1330DOI (Open Access)
-
Young unrelated donors confer a survival advantage for patients with myeloid malignancies compared to older siblingsIn: Leukemia, Vol. 39, 2025, Nr. 10, pp. 2523 – 2532DOI (Open Access)
-
Lymphoma accelerates T cell and tissue agingIn: Cancer Cell, Vol. 43, 2025, Nr. 10, pp. 1917 – 1936.e8DOI (Open Access)
-
Unraveling Relatlimab-Specific Biology Using Biomarker Analyses in Patients with Advanced Melanoma in RELATIVITY-047In: Clinical Cancer Research, Vol. 31, 2025, Nr. 17, pp. 3702 – 3714DOI (Open Access)
-
Functional synapses between neurons and small cell lung cancerIn: Nature, Vol. 646, 2025, Nr. 8087, pp. 1243 – 1253DOI (Open Access)
-
Fulminant myocarditis : outcome predictors in an international cohort studyIn: European Heart Journal, 2025, in press
-
ATXN3 regulates lysosome regeneration after damage by targeting K48-K63-branched ubiquitin chainsIn: The EMBO Journal, Vol. 44, 2025, Nr. 18, pp. 5086 – 5111DOI (Open Access)
-
Selective inhibition of mitochondrial Kv1.3 prevents and alleviates multiple sclerosis in vivoIn: EMBO Molecular Medicine, Vol. 17, 2025, Nr. 11, pp. 2901 – 2931DOI (Open Access)
-
TXNIP mediates LAT1/SLC7A5 endocytosis to limit amino acid uptake in cells entering quiescenceIn: The EMBO Journal, Vol. 44, 2025, Nr. 23, pp. 7119 – 7153DOI, Online Full Text (Open Access)
-
Transcription factor switching drives subtype-specific pancreatic cancerIn: Nature Genetics, Vol. 57, 2025, Nr. 12, pp. 3016 – 3026DOI (Open Access)
-
Adjuvant nivolumab and relatlimab in stage III/IV melanoma : the randomized phase 3 RELATIVITY-098 trialIn: Nature Medicine, Vol. 31, 2025, Nr. 12, pp. 4301 – 4309DOI (Open Access)
-
Polyamines sustain epithelial regeneration in aged intestines by modulating protein homeostasisIn: Nature Cell Biology, 2025, in pressDOI (Open Access)
-
Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response SignalingIn: Cancer Discovery, Vol. 15, 2025, Nr. 12, pp. 2437 – 2449DOI, Online Full Text (Open Access)
-
Cutaneous melanoma : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upIn: Annals of Oncology, Vol. 36, 2025, Nr. 1, pp. 10 – 30